176 related articles for article (PubMed ID: 26450632)
1. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.
Kamada M; Koshikawa N; Minegishi T; Kawada C; Karashima T; Shuin T; Seiki M
Cancer Sci; 2015 Dec; 106(12):1730-7. PubMed ID: 26450632
[TBL] [Abstract][Full Text] [Related]
2. Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.
Kiyokawa H; Yasuda H; Oikawa R; Okuse C; Matsumoto N; Ikeda H; Watanabe T; Yamamoto H; Itoh F; Otsubo T; Yoshimura T; Yoshida E; Nakagawa M; Koshikawa N; Seiki M
Cancer Sci; 2017 Jul; 108(7):1432-1439. PubMed ID: 28418226
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of urine laminin-γ2 monomer as a potent biomarker for non-muscle invasive bladder cancer.
Karashima T; Umemoto S; Kishida T; Osaka K; Nakagawa M; Yoshida E; Yoshimura T; Sakaguchi M; Nishimoto H; Tai M; Inoue K; Seiki M; Koshikawa N; Shuin T
Cancer Med; 2023 Feb; 12(3):2453-2462. PubMed ID: 35924681
[TBL] [Abstract][Full Text] [Related]
4. Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review.
Yasuda H; Nakagawa M; Kiyokawa H; Yoshida E; Yoshimura T; Koshikawa N; Itoh F; Seiki M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626121
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
Lotan Y; OʼSullivan P; Raman JD; Shariat SF; Kavalieris L; Frampton C; Guilford P; Luxmanan C; Suttie J; Crist H; Scherr D; Asroff S; Goldfischer E; Thill J; Darling D
Urol Oncol; 2017 Aug; 35(8):531.e15-531.e22. PubMed ID: 28366272
[TBL] [Abstract][Full Text] [Related]
6. Urine laminin P1 assessment discriminates between invasive and noninvasive urothelial cell carcinoma of the bladder.
Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
Urol Int; 1993; 51(4):204-8. PubMed ID: 8266611
[TBL] [Abstract][Full Text] [Related]
7. Urinary protein biomarker panel for the detection of recurrent bladder cancer.
Rosser CJ; Chang M; Dai Y; Ross S; Mengual L; Alcaraz A; Goodison S
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1340-5. PubMed ID: 24714076
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
[TBL] [Abstract][Full Text] [Related]
9. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
10. Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.
Babu S; Kim NW; Wu M; Chan I; Escobar-Hoyos LF; Shroyer KR
Am J Clin Pathol; 2021 Oct; 156(5):926-933. PubMed ID: 34086841
[TBL] [Abstract][Full Text] [Related]
11. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of urinary soluble Fas in screening for bladder cancer.
Srivastava AK; Singh PK; Singh D; Dalela D; Rath SK; Bhatt ML
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e215-21. PubMed ID: 24576318
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
[TBL] [Abstract][Full Text] [Related]
15. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
Nakagawa M; Karashima T; Kamada M; Yoshida E; Yoshimura T; Nojima M; Inoue K; Shuin T; Seiki M; Koshikawa N
Biomark Res; 2017; 5():29. PubMed ID: 29046806
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with survivin as a biomarker for urothelial bladder cancer.
Horstmann M; Bontrup H; Hennenlotter J; Taeger D; Weber A; Pesch B; Feil G; Patschan O; Johnen G; Stenzl A; Brüning T
World J Urol; 2010 Jun; 28(3):399-404. PubMed ID: 20309562
[TBL] [Abstract][Full Text] [Related]
18. Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.
Fantony JJ; Longo TA; Gopalakrishna A; Owusu R; Lance RS; Foo WC; Inman BA; Abern MR
Cancer Biomark; 2017; 18(4):381-387. PubMed ID: 28106542
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis.
Hindermann W; Berndt A; Haas KM; Wunderlich H; Katenkamp D; Kosmehl H
Cancer Detect Prev; 2003; 27(2):109-15. PubMed ID: 12670521
[TBL] [Abstract][Full Text] [Related]
20. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
Arnold SA; Loomans HA; Ketova T; Andl CD; Clark PE; Zijlstra A
Clin Exp Metastasis; 2016 Jan; 33(1):29-44. PubMed ID: 26456754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
